Subcutaneously-administered ganglioside-based vaccine compositions

Details for Australian Patent Application No. 2004216554 (hide)

Owner Centro De Inmunologia Molecular

Inventors Mesa Pardillo, Circe; Fernandez Molina, Luis Enrique

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004216554

PCT Pub. Number WO2004/075811

Priority 47-2003 27.02.03 CU

Filing date 27 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 20 May 2010

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/095 (2006.01) Medicinal preparations containing antigens or antibodies - Neisseria

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/075811 Priority application(s): WO2004/075811

20 May 2010 Application Accepted

  Published as AU-B-2004216554

16 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216559-Dosage form having a saccharide matrix

2004216551-Preparation for repairing cartilage tissue, especially articular cartilage defects